Activity from announced rounds
Cloverleaf Bio is developing engineered transfer RNA therapies that use a modified tRNA payload to inhibit cancer cells' RNA-modifying enzymes. Its lead program targets liver cancer and is advancing toward clinical testing; a second antibody-tRNA program for colorectal cancer remains preclinical.
Poseidon Aerospace is developing unmanned cargo aircraft for commercial freight and defense logistics. Its Egret short-takeoff-and-landing freighter and Heron seaplane are designed to move heavy loads between small, remote or water-based operating sites without an onboard pilot.
Develops AI-powered autonomous directed-energy systems to detect and neutralize drone threats